Rap1a activation by CalDAG-GEFI and p38 MAPK is involved in E-selectin-dependent slow leukocyte rolling - PubMed (original) (raw)
Rap1a activation by CalDAG-GEFI and p38 MAPK is involved in E-selectin-dependent slow leukocyte rolling
Anika Stadtmann et al. Eur J Immunol. 2011 Jul.
Abstract
Rolling leukocytes are exposed to different adhesion molecules and chemokines. Neutrophils rolling on E-selectin induce integrin αLβ2-mediated slow rolling on ICAM-1 by activating a phospholipase C (PLC)γ2-dependent and a separate PI3Kγ-dependent pathway. E-selectin-signaling cooperates with chemokine signaling to recruit neutrophils into inflamed tissues. However, the distal signaling pathway linking PLCγ2 (Plcg2) to αLβ2-activation is unknown. To identify this pathway, we used different Tat-fusion-mutants and gene-deficient mice in intravital microscopy, autoperfused flow chamber, peritonitis, and biochemical studies. We found that the small GTPase Rap1 is activated following E-selectin engagement and that blocking Rap1a in Pik3cg-/- mice by a dominant-negative Tat-fusion mutant completely abolished E-selectin-mediated slow rolling. We identified CalDAG-GEFI (Rasgrp2) and p38 MAPK as key signaling intermediates between PLCγ2 and Rap1a. Gαi-independent leukocyte adhesion to and transmigration through endothelial cells in inflamed postcapillary venules of the cremaster muscle were completely abolished in Rasgrp2-/- mice. The physiological importance of CalDAG-GEFI in E-selectin-dependent integrin activation is shown by complete inhibition of neutrophil recruitment into the inflamed peritoneal cavity of Rasgrp2-/- leukocytes treated with pertussis toxin to block Gαi-signaling. Our data demonstrate that Rap1a activation by p38 MAPK and CalDAG-GEFI is involved in E-selectin-dependent slow rolling and leukocyte recruitment.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Conflict of interest statement
Conflict-of-interest disclosure
The authors declare no competing financial interests.
Figures
Figure 1. Rap1a is involved in E-selectin mediated slow rolling
(A) Bone-marrow-derived neutrophils from WT mice were lysed, treated with GTPγS (activator) or GDP (inactivator), and then purified using GST-RalGDS-RBD. Proteins were analyzed by Western blotting using a specific anti-Rap1 antibody. (B) Bone-marrow-derived neutrophils from WT mice were plated for different time intervals in multiwell plates with or without E-selectin coating, after which lysates were prepared. Western blots of activated Rap1 (affinity-precipitated Rap1-GTP) demonstrate Rap1 activation following E-selectin stimulation. Results are representative of 4 individual experiments. (C) Rap-1-GTP normalized to Rap1-GTP in unstimulated WT neutrophils (n=4). (D) Rolling velocities of reconstituted Lys-M-GFP+ leukocytes and Pik3cg−/− leukocytes pretreated with either wild type Rap1a TAT-peptides (Rap1-WT) or blocking Rap1a TAT-peptides (Rap1-DN) in inflamed postcapillary venules of the cremaster muscle of Lys-M-GFP+ mice and WT mice. The reconstituted cells were pretreated with PTx, and the mice were pretreated with anti–P-selectin mAb. Average rolling velocity of leukocytes presented as mean ± SEM. (D) Rolling velocities of reconstituted Plcg2−/− leukocytes pretreated with either wild type Rap1a TAT-peptides (Rap1-WT) or constitutively active Rap1a TAT-peptides (Rap1-CA) in inflamed postcapillary venules of the cremaster muscle of Lys-M-GFP+ mice. The reconstituted cells were pretreated with PTx, and the mice were pretreated with anti–P-selectin mAb. Average rolling velocity of leukocytes presented as mean ± SEM. #P < 0.05. * P < 0.05 vs. other groups.
Figure 2. Elimination of CalDAG-GEFI impairs E-selectin mediated slow rolling
(A) Carotid cannulas were placed in WT mice (n=3) and Rasgrp2−/− mice (n=3) and connected to autoperfused flow chambers. The wall shear stress in all flow chamber experiments was 5–6 dynes/cm2. (B) Rolling velocity of Rasgrp2−/− neutrophils on E-selectin alone or E-selectin/ICAM-1 of either PI3kγ-inhibitor (define molecule)- or DMSO-pretreated mice. Average rolling velocity of neutrophils on E-selectin (left) and E-selectin/ICAM-1 (right) presented as mean ± SEM. #P < 0.05.
Figure 3. CalDAG-GEFI and p38 MAPK are located in the PLCγ2-dependent signaling pathway
(A) Rolling velocity of WT neutrophils on E-selectin alone or E-selectin/ICAM-1 of either PLC inhibitor (U73122)- or DMSO-pretreated whole blood. (B) Rolling velocity of Rasgrp2−/− neutrophils on E-selectin alone or E-selectin plus ICAM-1 of either U73122- or DMSO-pretreated whole blood. (C) Rolling velocity of Rasgrp2−/− neutrophils on E-selectin alone or E-selectin/ICAM-1 of either p38 MAPK inhibitor (SB203580)– or DMSO-pretreated mice. Data presented as mean ± SEM from 3 mice. (D) (D) Whole human heparinized blood was treated with the p38 MAPK inhibitor SB203580 (10μM for 30 minutes at RT) or SB203580 (10μM) plus anti–LFA-1 antibody (10 μg/mL for 20 minutes at RT), then perfused through flow chambers coated with E-selectin with or without ICAM-1. Average rolling velocity of neutrophils on E-selectin (left) and E-selectin/ICAM-1 (right) is presented as mean ± SEM (n=3). (E) Whole human blood was treated with either Rap1-WT or Rap1-DN peptides (1μM for 30 minutes at RT), then perfused through flow chambers coated with E-selectin with or without ICAM-1. Average rolling velocity of neutrophils on E-selectin (left) and E-selectin/ICAM-1 (right) is presented as mean ± SEM (n=3). (F) HL-60 cells transfected with either siRNA specific for CalDAG-GEFI or a non-silencing control sequence were perfused through flow chambers coated with E-selectin and isotype antibody or KIM127 for 2 minutes at 5.94 dyn/cm2. The number of adherent cells per one representative field of view was determined. Data are from 3 experiments. #P < 0.05.
Figure 4. CalDAG-GEFI is involved in E-selectin mediated slow rolling in vivo
(A) Mixed chimeric mice were generated by injecting bone marrow cells from Rasgrp2−/− mice and LysM-GFP+ WT mice into lethally irradiated WT mice. Cumulative histogram of rolling velocity of 120 GFP+ leukocytes (wild-type, open circle), 120 GFP− leukocytes (Rasgrp2−/−, filled triangle), and 120 Rasgrp2−/− leukocytes treated with a blocking LFA-1 antibody (Rasgrp2−/− + anti-LFA-1-antibody, open triangle) in inflamed cremaster muscle venules of mixed chimeric mice (n=4) treated with PTx and a monoclonal blocking P-selectin antibody. Insert: Mean ± SEM. #P<0.05. (B) Rolling velocities of reconstituted Lys-M-GFP+ leukocytes and Rasgrp2−/−- leukocytes pretreated with wild-type (WT) or constitutive-active (CA) Rap1a TAT-peptides in inflamed postcapillary venules of the cremaster muscle of Lys-M-GFP+ mice and WT mice. The reconstituted cells were pretreated with PTx, and the mice were pretreated with anti–P-selectin mAb. Average rolling velocity of leukocytes presented as mean ± SEM. * P < 0.05 vs. other groups. (C) Rap1a is involved in L-selectin clustering in rolling leukocytes. Wild-type leukocytes pretreated with either Rap1a-WT or Rap1a-DN peptides were injected in TNF-alpha treated mice before analysis of L-selectin redistribution by intravital microscopy. Results are derived from the analysis of three mice per group. #P<0.05.
Figure 5. PLCγ2 is upstream of CalDAG-GEFI and p38 MAPK and both are involved in Rap1 activation
Bone marrow–derived neutrophils from WT mice (untreated or pretreated with different inhibitors: phospholipase C: U73122, p38 MAPK: SB203580), Pik3cg−/− mice, Plcg2−/− mice, and Rasgrp2−/− mice were plated on uncoated (unstimulated) or E-selectin–coated wells, and then lysates were prepared. (A-C) Total Rap1 and GTP-bound Rap1 protein levels were measured in untreated or pretreated neutrophils from WT mice (A, untreated or pretreated with a phospholipase inhibitor (U73122)), Plcg2−/− mice (B), and Rasgrp2−/− mice (C) after stimulation with E-selectin. Representative blots from 3 independent experiments are shown. (D) Total Rap1 and GTP-bound Rap1 protein levels were measured in unstimulated and stimulated neutrophils from WT mice after inhibiting p38 MAPK (I, SB203580, 10μM). Representative blots from 3 independent experiments are shown. (E) Total Rap1 and GTP-bound Rap1 protein levels were measured in unstimulated and stimulated neutrophils from Pik3cg−/− mice. Representative blots from 3 independent experiments are shown. (F+G) Bone-marrow-derived neutrophils from WT mice (untreated or pretreated with a phospholipase inhibitor (U73122)) and Rasgrp2−/− mice were plated in multiwell plates with or without E-selectin coating for 10 minutes, after which lysates were prepared and immunoblotted with antibody to phosphorylated p38 MAPK (phospho-p38) or total p38. Representative blots from 3 independent experiments are shown.
Figure 6. Gαi-independent leukocyte adhesion, transmigration and recruitment is defective in Rasgrp2−/− mice
All mice were treated with pertussis toxin (PTx) to block Gαi-signaling. (A) Numbers of adherent cells per square millimeter in murine cremaster muscle venules. The cremaster muscle was exteriorized 2 hours after intrascrotal injection of 500 ng TNF-α in WT and Rasgrp2−/− mice. (B) Number of extravasated leukocytes in inflamed cremasteric venules of WT (n=3) and Rasgrp2−/− mice (n=3) per 1.5 × 104 μm2 tissue area. The measurements were performed 2 hours after intrascrotal TNF-α injection. (C+D) Representative reflected light oblique transillumination microscopic pictures of cremaster muscle postcapillary venules of PTx pretreated WT mice (C) and Rasgrp2−/− mice (D) 2 h after TNF-α application. Demarcations on each side of the venule determine the areas in which extravasated leukocytes were counted. Scale bar equals 50 μm. (E) Neutrophil influx into the peritoneal cavity 8 hrs after 1 ml injection of 4% thioglycollate into mixed chimeric mice generated by injecting bone marrow from WT mice and Rasgrp2−/− mice into lethally irradiated WT mice. After 6 weeks, , mice received 4μg PTx i.v. to block Gαi-signaling followed bye thioglycollate injection. Migration efficiency was calculated (number of recruited neutrophils/number of neutrophils in the blood). Data presented as mean ± SEM from 5 mice. #P < 0.05.
Similar articles
- Tyrosine kinase Btk regulates E-selectin-mediated integrin activation and neutrophil recruitment by controlling phospholipase C (PLC) gamma2 and PI3Kgamma pathways.
Mueller H, Stadtmann A, Van Aken H, Hirsch E, Wang D, Ley K, Zarbock A. Mueller H, et al. Blood. 2010 Apr 15;115(15):3118-27. doi: 10.1182/blood-2009-11-254185. Epub 2010 Feb 18. Blood. 2010. PMID: 20167705 Free PMC article. - E-selectin engages PSGL-1 and CD44 through a common signaling pathway to induce integrin alphaLbeta2-mediated slow leukocyte rolling.
Yago T, Shao B, Miner JJ, Yao L, Klopocki AG, Maeda K, Coggeshall KM, McEver RP. Yago T, et al. Blood. 2010 Jul 22;116(3):485-94. doi: 10.1182/blood-2009-12-259556. Epub 2010 Mar 18. Blood. 2010. PMID: 20299514 Free PMC article. - PSGL-1 engagement by E-selectin signals through Src kinase Fgr and ITAM adapters DAP12 and FcR gamma to induce slow leukocyte rolling.
Zarbock A, Abram CL, Hundt M, Altman A, Lowell CA, Ley K. Zarbock A, et al. J Exp Med. 2008 Sep 29;205(10):2339-47. doi: 10.1084/jem.20072660. Epub 2008 Sep 15. J Exp Med. 2008. PMID: 18794338 Free PMC article. - E-selectin ligands as mechanosensitive receptors on neutrophils in health and disease.
Chase SD, Magnani JL, Simon SI. Chase SD, et al. Ann Biomed Eng. 2012 Apr;40(4):849-59. doi: 10.1007/s10439-011-0507-y. Epub 2012 Jan 24. Ann Biomed Eng. 2012. PMID: 22271244 Free PMC article. Review. - RAP1-GTPase signaling and platelet function.
Stefanini L, Bergmeier W. Stefanini L, et al. J Mol Med (Berl). 2016 Jan;94(1):13-9. doi: 10.1007/s00109-015-1346-3. Epub 2015 Oct 1. J Mol Med (Berl). 2016. PMID: 26423530 Free PMC article. Review.
Cited by
- To Gain Insights into the Pathophysiological Mechanisms of the Thrombo-Inflammatory Process in the Atherosclerotic Plaque.
Nappi F. Nappi F. Int J Mol Sci. 2023 Dec 19;25(1):47. doi: 10.3390/ijms25010047. Int J Mol Sci. 2023. PMID: 38203218 Free PMC article. Review. - Distinct bidirectional regulation of LFA1 and α4β7 by Rap1 and integrin adaptors in T cells under shear flow.
Kamioka Y, Ueda Y, Kondo N, Tokuhiro K, Ikeda Y, Bergmeier W, Kinashi T. Kamioka Y, et al. Cell Rep. 2023 Jun 27;42(6):112580. doi: 10.1016/j.celrep.2023.112580. Epub 2023 Jun 1. Cell Rep. 2023. PMID: 37267105 Free PMC article. - Spatiotemporal characteristics of P-selectin-induced β2 integrin activation of human neutrophils under flow.
Sun X, Huang B, Pan Y, Fang J, Wang H, Ji Y, Ling Y, Guo P, Lin J, Li Q, Fang Y, Wu J. Sun X, et al. Front Immunol. 2022 Nov 10;13:1023865. doi: 10.3389/fimmu.2022.1023865. eCollection 2022. Front Immunol. 2022. PMID: 36439190 Free PMC article. - Thromboinflammation: From Atherosclerosis to COVID-19.
Wagner DD, Heger LA. Wagner DD, et al. Arterioscler Thromb Vasc Biol. 2022 Sep;42(9):1103-1112. doi: 10.1161/ATVBAHA.122.317162. Epub 2022 Jul 8. Arterioscler Thromb Vasc Biol. 2022. PMID: 35861953 Free PMC article. Review. - Selectin-Mediated Signaling-Shedding Light on the Regulation of Integrin Activity in Neutrophils.
Cappenberg A, Kardell M, Zarbock A. Cappenberg A, et al. Cells. 2022 Apr 12;11(8):1310. doi: 10.3390/cells11081310. Cells. 2022. PMID: 35455989 Free PMC article. Review.
References
- Anderson DC, Springer TA. Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. Annu Rev Med. 1987;38:175–194. - PubMed
- Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol. 2006;6:173–182. - PubMed
- Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell. 1991;67:1033–1036. - PubMed
- Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301–314. - PubMed
- Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7:678–689. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 HL094594/HL/NHLBI NIH HHS/United States
- R01 HL058108-11/HL/NHLBI NIH HHS/United States
- P0I HL056949/HL/NHLBI NIH HHS/United States
- P01 HL056949/HL/NHLBI NIH HHS/United States
- R01 HL058108/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous